Rational therapy for relapsing multiple sclerosis

Lancet Neurology

Volumn 2, Issue 5, 2003, Pages 271-272

  Wolinsky, Jerry S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; IMMUNOMODULATING AGENT; INTERFERON BETA SERINE; MITOXANTRONE; NATALIZUMAB; IMMUNOLOGICAL ADJUVANT; MONOCLONAL ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT SURVEY; ADULT; ARTICLE; IMMUNOLOGY; IMMUNOTHERAPY; INFLAMMATION; PATHOLOGY;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOTHERAPY; INFLAMMATION; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 0042011476     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00375-2     Document Type: Letter

References (11)

1. Compston A., Coles A. Multiple sclerosis. Lancet. 359:2002;1221-1231.
2. Filippini G., Munari L., Incorvaia B., et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet. 361:2003;545-552.
3. Wolinsky J.S., Comi G., Filippi M., et al. Copaxone's effect on MRI-monitored disease in relapsing MS is reproducible and sustained. Neurology. 59:2002;1284-1286.
4. Hartung H.-P., Gonsette R., König N., et al. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet. 360:2002;2018-2025.
5. Yong V.W. Differential mechanisms of action of interferon-b and glatiramer acetate in MS. Neurology. 59:2002;802-808.
6. Edan G., Miller D., Clanet M., et al. Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry. 62:1997;112-118.
7. Martino G., Adorini L., Rieckmann P., et al. Inflammation in multiple sclerosis: the good, the bad, and the complex. Lancet Neurology. 1:2002;499-509.
8. Neuhaus O., Strasser-Fuchs S., Fazekas F., et al. Statins as immunomodulators: comparison with interferon β-1b in MS. Neurology. 59:2002;990-997.
9. van der Laan L.J., van der Goes A., Wauben M.H., et al. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats. J Neurosci Res. 67:2002;191-199.
10. Miller D.H., Khan O.A., Sheremata W.A., et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 348:2003;15-23.
11. Wolinsky J.S., Narayana P.A. Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain. Curr Opin Neurol. 15:2002;247-251.